Bridgeway Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,023
| Closed | -$37K | – | 1508 |
|
|
2022
Q3 | $37K | Hold |
2,023
| – | – | ﹤0.01% | 1365 |
|
|
2022
Q2 | $102K | Hold |
2,023
| – | – | ﹤0.01% | 1220 |
|
|
2022
Q1 | $285K | Sell |
2,023
-570
| -22% | -$80.3K | 0.01% | 1093 |
|
|
2021
Q4 | $443K | Sell |
2,593
-396
| -13% | -$67.7K | 0.01% | 1016 |
|
|
2021
Q3 | $1.49M | Sell |
2,989
-417
| -12% | -$208K | 0.03% | 712 |
|
|
2021
Q2 | $1.71M | Sell |
3,406
-330
| -9% | -$165K | 0.03% | 683 |
|
|
2021
Q1 | $1.89M | Hold |
3,736
| – | – | 0.04% | 639 |
|
|
2020
Q4 | $1.78M | Sell |
3,736
-166
| -4% | -$79.2K | 0.04% | 560 |
|
|
2020
Q3 | $1.12M | Hold |
3,902
| – | – | 0.03% | 637 |
|
|
2020
Q2 | $746K | Buy |
+3,902
| New | +$746K | 0.02% | 742 |
|
|
2018
Q4 | – | Sell |
-333
| Closed | -$51K | – | 1496 |
|
|
2018
Q3 | $51K | Hold |
333
| – | – | ﹤0.01% | 1410 |
|
|
2018
Q2 | $220K | Buy |
+333
| New | +$220K | ﹤0.01% | 1298 |
|
|
2017
Q1 | – | Sell |
-183
| Closed | -$49K | – | 1491 |
|
|
2016
Q4 | $49K | Hold |
183
| – | – | ﹤0.01% | 1382 |
|
|
2016
Q3 | $41K | Sell |
183
-911
| -83% | -$204K | ﹤0.01% | 1405 |
|
|
2016
Q2 | $424K | Buy |
1,094
+150
| +16% | +$58.1K | 0.01% | 1114 |
|
|
2016
Q1 | $637K | Buy |
944
+588
| +165% | +$397K | 0.01% | 947 |
|
|
2015
Q4 | $374K | Hold |
356
| – | – | 0.01% | 1147 |
|
|
2015
Q3 | $309K | Hold |
356
| – | – | 0.01% | 1208 |
|
|
2015
Q2 | $253K | Hold |
356
| – | – | 0.01% | 1299 |
|
|
2015
Q1 | $804K | Hold |
356
| – | – | 0.02% | 884 |
|
|
2014
Q4 | $366K | Sell |
356
-94
| -21% | -$96.6K | 0.01% | 1170 |
|
|
2014
Q3 | $477K | Hold |
450
| – | – | 0.01% | 1093 |
|
|
2014
Q2 | $1.13M | Buy |
450
+150
| +50% | +$376K | 0.03% | 724 |
|
|
2014
Q1 | $572K | Sell |
300
-2
| -0.7% | -$3.81K | 0.02% | 1012 |
|
|
2013
Q4 | $647K | Buy |
302
+2
| +0.7% | +$4.29K | 0.02% | 920 |
|
|
2013
Q3 | $675K | Buy |
+300
| New | +$675K | 0.02% | 889 |
|